OK Biotech Past Earnings Performance
Past criteria checks 1/6
OK Biotech's earnings have been declining at an average annual rate of -24.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 0.4% per year. OK Biotech's return on equity is 1.2%, and it has net margins of 1.5%.
Key information
-24.3%
Earnings growth rate
-31.9%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | 0.4% |
| Return on equity | 1.2% |
| Net Margin | 1.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings
Aug 20
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend
Apr 26Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)
Apr 04OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet
Mar 17Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?
Mar 01Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?
Feb 15A Look At OK Biotech's (TPE:4155) Share Price Returns
Jan 31We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide
Jan 17
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend
Jan 03Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)
Dec 21Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly
Dec 08Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?
Nov 23Revenue & Expenses Breakdown
How OK Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,525 | 23 | 126 | 61 |
| 30 Jun 24 | 1,343 | 48 | 145 | 46 |
| 31 Mar 24 | 1,223 | 21 | 143 | 51 |
| 31 Dec 23 | 1,192 | 3 | 170 | 47 |
| 30 Sep 23 | 1,238 | 29 | 185 | 40 |
| 30 Jun 23 | 1,271 | 74 | 189 | 45 |
| 31 Mar 23 | 1,387 | 113 | 184 | 45 |
| 31 Dec 22 | 1,484 | 143 | 187 | 49 |
| 30 Sep 22 | 1,519 | 147 | 198 | 47 |
| 30 Jun 22 | 1,520 | 116 | 182 | 42 |
| 31 Mar 22 | 1,385 | 62 | 177 | 33 |
| 31 Dec 21 | 1,263 | 43 | 155 | 29 |
| 30 Sep 21 | 1,358 | 81 | 146 | 33 |
| 30 Jun 21 | 1,391 | 92 | 151 | 42 |
| 31 Mar 21 | 1,410 | 113 | 145 | 43 |
| 31 Dec 20 | 1,484 | 130 | 162 | 45 |
| 30 Sep 20 | 1,407 | 127 | 149 | 41 |
| 30 Jun 20 | 1,356 | 139 | 148 | 38 |
| 31 Mar 20 | 1,330 | 143 | 155 | 37 |
| 31 Dec 19 | 1,241 | 126 | 155 | 33 |
| 30 Sep 19 | 1,169 | 133 | 171 | 34 |
| 30 Jun 19 | 1,145 | 144 | 159 | 33 |
| 31 Mar 19 | 1,107 | 148 | 148 | 36 |
| 31 Dec 18 | 1,120 | 161 | 132 | 41 |
| 30 Sep 18 | 1,075 | 148 | 125 | 40 |
| 30 Jun 18 | 1,157 | 139 | 129 | 40 |
| 31 Mar 18 | 1,239 | 143 | 118 | 37 |
| 31 Dec 17 | 1,233 | 127 | 118 | 33 |
| 30 Sep 17 | 1,281 | 116 | 100 | 30 |
| 30 Jun 17 | 1,182 | 80 | 93 | 24 |
| 31 Mar 17 | 1,092 | 74 | 90 | 23 |
| 31 Dec 16 | 1,040 | 85 | 88 | 20 |
| 30 Sep 16 | 964 | 97 | 112 | 21 |
| 30 Jun 16 | 942 | 123 | 131 | 22 |
| 31 Mar 16 | 894 | 122 | 140 | 20 |
| 31 Dec 15 | 857 | 111 | 148 | 20 |
| 30 Sep 15 | 758 | 97 | 136 | 18 |
| 30 Jun 15 | 660 | 83 | 125 | 15 |
| 31 Mar 15 | 647 | 77 | 121 | 19 |
| 31 Dec 14 | 634 | 71 | 117 | 23 |
| 30 Sep 14 | 784 | 84 | 106 | 26 |
| 30 Jun 14 | 934 | 96 | 96 | 30 |
| 31 Mar 14 | 1,004 | 117 | 89 | 26 |
| 31 Dec 13 | 1,074 | 138 | 82 | 23 |
Quality Earnings: 4155 has high quality earnings.
Growing Profit Margin: 4155's current net profit margins (1.5%) are lower than last year (2.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4155's earnings have declined by 24.3% per year over the past 5 years.
Accelerating Growth: 4155's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4155 had negative earnings growth (-19%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.7%).
Return on Equity
High ROE: 4155's Return on Equity (1.2%) is considered low.